V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270010361 | 270006078 | 1.78 | 89.65 | Disease modification (D) | 2014-01-04 | 2014-01-04 | CYCLOPHOSPHAMIDE + ETOPOSIDE + VINCRISTINE | Y | N | 270024662 | RITUXIMAB |
| 270010362 | 270006078 | null | null | null | 2013-03-05 | 2013-03-16 | R GCVP | 2 | null | 270024662 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270010363 | 270006079 | 1.86 | 89.9 | Curative (C) | 2017-08-28 | 2017-09-07 | IBRUTINIB | N | Y | 270024685 | NOT MATCHED |
| 270010364 | 270006079 | 1.78 | 74.3 | null | 2015-05-22 | 2015-06-11 | BREVITY TRIAL | N | N | 270024685 | DHAP |
| 270010365 | 270006080 | 1.8 | 66.2 | Curative (C) | 2015-01-01 | 2015-01-17 | Cyclophosphamide + Etoposide (PO) | N | N | 270024709 | NOT MATCHED |
| 270010366 | 270006081 | null | null | Neo-adjuvant (N) | 2013-04-05 | 2013-04-21 | CVP R | null | null | 270024724 | CVP R |
| 270010367 | 270006082 | 1.64 | 62 | Curative (C) | 2014-05-30 | 2014-06-13 | Cetuximab 14 day | 2 | N | 270024728 | CETUXIMAB + IRINOTECAN + MDG |
| 270010368 | 270006083 | 1.68 | 114.2 | Adjuvant (A) | 2017-09-22 | 2017-10-02 | Rituximab | N | N | 270024737 | RITUXIMAB |
| 270010369 | 270006084 | 1.82 | 116.3 | Palliative (P) | 2015-03-06 | 2015-03-12 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270024741 | RITUXIMAB |
| 270010370 | 270006085 | 1.71 | 102.5 | null | null | 2014-11-18 | DHAP | null | null | 270024751 | CARBOPLATIN + RT |
| 270010371 | 270012987 | 1.94 | 58.8 | Curative (C) | 2014-07-26 | 2014-07-26 | CVP R | Y | N | 270024754 | DHAP |
| 270010372 | 270006086 | 1.77 | 63.8 | Curative (C) | 2013-04-14 | 2013-05-01 | IBRUTINIB | 02 | N | 270024764 | CYCLOPHOSPHAMIDE + DACARBAZINE + VINCRISTINE |
| 270010373 | 270006087 | 1.65 | 52.3 | Curative (C) | 2017-08-30 | 2017-09-12 | HD Lymph Pred EuroNet-PHL-LP1 CVP | 02 | N | 270024769 | VINBLASTINE |
| 270010374 | 270006088 | 1.69 | 69 | Curative (C) | 2016-12-26 | 2016-12-27 | CHOP | N | N | 270024770 | CARBOPLATIN |
| 270010375 | 270006089 | 1.84 | 58 | Curative (C) | null | 2013-02-18 | null | 02 | N | 270024771 | GDP |
| 270010376 | 270006090 | null | 92 | Not known (9) | 2017-02-09 | 2017-02-13 | Mini BEAM | N | N | 270024778 | ETOPOSIDE |
| 270010377 | 270006090 | 1.65 | 63 | Palliative (P) | 2017-07-13 | 2017-07-21 | Rituximab | N | N | 270024778 | OXALIPLATIN + MDG + PANITUMUMAB |
| 270010378 | 270006091 | 1.8 | 63 | Curative (C) | 2014-12-11 | 2014-12-11 | ICE (no GCSF) | N | N | 270024783 | NOT MATCHED |
| 270010380 | 270006093 | null | 81.7 | Curative (C) | 2018-03-13 | 2018-03-22 | DACARBAZINE + DOXORUBICIN + VINCRISTINE | N | N | 270024790 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 270010381 | 270006094 | 1.83 | 93 | Disease modification (D) | 2018-05-17 | 2018-05-24 | HD Lymph Pred EuroNet-PHL-LP1 CVP | N | N | 270024795 | ABVD R |
| 270010382 | 270006095 | 1.55 | 68.9 | Palliative (P) | 2015-09-04 | 2015-10-12 | CVP | N | N | 270024796 | CVP R |
| 270010383 | 270006096 | 2 | 85 | Palliative (P) | 2017-04-26 | 2018-05-11 | LEAM | N | N | 270024801 | NOT MATCHED |
| 270010384 | 270006096 | 1.52 | 73.9 | null | 2013-09-24 | 2013-09-26 | CVP R | N | N | 270024801 | LENALIDOMIDE |
| 270010385 | 270016110 | 1.66 | 60.2 | Curative (C) | 2016-09-01 | 2016-09-01 | null | 2 | N | 270024824 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270010386 | 270016110 | 1.6 | 52 | Palliative (P) | 2014-10-26 | 2014-11-02 | Rituximab (Maintenance) | 2 | N | 270024824 | NOT MATCHED |
| 270010387 | 270016110 | 1.78 | null | Curative (C) | null | 2013-05-25 | ESHAP R | null | null | 270024824 | CVP R |
| 270010388 | 270006097 | 1.7 | 101 | Curative (C) | 2014-03-21 | 2014-04-23 | ECHELON 1 TRIAL | N | N | 270024857 | MITOMYCIN INTRAVESICULAR |
| 270010389 | 270006098 | null | null | null | 2015-02-19 | 2015-02-19 | Imatinib 400mg | N | N | 270024861 | METHOTREXATE INTRATHECAL |
| 270010390 | 270006099 | 1.8 | 107.3 | Palliative (P) | 2017-08-19 | 2017-08-22 | Rituximab | 2 | N | 270024866 | NOT MATCHED |
| 270010391 | 270006100 | 1.8 | null | Curative (C) | 2015-06-11 | 2015-06-16 | CVP R | N | N | 270024867 | VEDEX |
| 270010392 | 270006101 | 1.78 | 76 | Curative (C) | 2014-07-24 | 2014-08-22 | Rituximab (Maintenance) | N | N | 270024871 | NOT MATCHED |
| 270010393 | 270006102 | 1.7 | 74 | Neo-adjuvant (N) | 2016-07-04 | 2016-07-04 | CAP | 2 | N | 270024874 | CYCLOPHOSPHAMIDE + DACARBAZINE + VINCRISTINE |
| 270010394 | 270006103 | 1.63 | 63 | Curative (C) | null | 2017-08-09 | IBRUTINIB | Y | N | 270024875 | NOT MATCHED |
| 270010395 | 270012990 | 1.8 | 78.3 | Curative (C) | 2017-11-18 | 2017-11-22 | FEC 100 | 01 | N | 270024883 | CVP R |
| 270010396 | 270012990 | 1.71 | 47.4 | null | 2013-09-03 | 2013-09-16 | CHOP | 02 | Y | 270024883 | NOT MATCHED |
| 270010397 | 270006104 | 1.55 | 42.7 | Disease modification (D) | 2014-09-21 | 2014-09-24 | R ABVD | N | N | 270024890 | CAP |
| 270010398 | 270006104 | 1.76 | 77.9 | Disease modification (D) | 2018-01-13 | 2018-01-16 | Oxaliplatin + Raltitrexed | 02 | N | 270024890 | BRENTUXIMAB |
| 270010399 | 270006105 | 1.8 | 51.6 | null | 2016-12-03 | 2016-12-16 | CVP R | 01 | N | 270024893 | DACARBAZINE |
| 270010400 | 270006106 | 1.68 | 79.8 | Curative (C) | 2016-10-13 | 2016-11-09 | HD Lymph Pred EuroNet-PHL-LP1 CVP | 02 | N | 270024894 | RATHL TRIAL |
| 270010401 | 270006107 | 1.62 | null | T | 2014-05-20 | 2014-05-23 | IBRUTINIB | 2 | N | 270024897 | GDP |
| 270010402 | 270006107 | 1.7 | 109.2 | Curative (C) | 2015-11-19 | 2015-11-23 | Vinblastine | N | N | 270024897 | CLADRIBINE + RITUXIMAB |
| 270010403 | 270006107 | 1.65 | 72.6 | Curative (C) | 2017-04-16 | 2017-04-18 | CETUXIMAB + RT | 02 | N | 270024897 | IMATINIB |
| 270010404 | 270006107 | 1.73 | 98 | Palliative (P) | 2016-01-23 | 2016-02-11 | Bevacizumab 5mg/kg | 2 | Y | 270024897 | CLADRIBINE + RITUXIMAB |
| 270010405 | 270006107 | null | 62.9 | Palliative (P) | 2016-01-24 | 2016-02-09 | CARBOPLATIN + FLUOROURACIL | N | N | 270024897 | UKALL2011 |
| 270010406 | 270006108 | 1.65 | 81.5 | null | 2017-08-04 | 2017-08-05 | ESHAP | N | N | 270024914 | RITUXIMAB |
| 270010407 | 270006109 | 1.59 | 81.5 | Curative (C) | 2013-09-28 | 2013-10-19 | DHAP | 02 | N | 270024923 | NOT MATCHED |
| 270010408 | 270006109 | null | 58.5 | null | 2014-03-20 | 2014-03-26 | HD Lymph Pred EuroNet-PHL-LP1 CVP | N | N | 270024923 | BRENTUXIMAB |
| 270010409 | 270016113 | 1.69 | 71.8 | Disease modification (D) | 2017-10-15 | 2017-10-15 | CTD | 2 | N | 270024946 | BRENTUXIMAB |
| 270010410 | 270006110 | null | null | Adjuvant (A) | 2016-07-28 | 2016-08-29 | Rituximab (Maintenance) | 99 | null | 270024971 | DHAP |
| 270010412 | 270006112 | null | null | Curative (C) | 2017-06-26 | 2018-01-21 | Hydroxycarbamide | Y | N | 270024981 | CHOP |